Killer cell Immunoglobulin-like Receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition
| dc.contributor.author | Saunders, Philippa M. | * |
| dc.contributor.author | Pymm, Phillip | * |
| dc.contributor.author | Pietra, Gabriella | * |
| dc.contributor.author | Hughes, Victoria A. | * |
| dc.contributor.author | Hitchen, Corinne | * |
| dc.contributor.author | O'Connor, Geraldine M. | * |
| dc.contributor.author | Loiacono, Fabrizio | * |
| dc.contributor.author | Widjaja, Jacqueline M. | * |
| dc.contributor.author | Price, David A. | * |
| dc.contributor.author | Falco, Michela | * |
| dc.contributor.author | Mingari, Maria C. | * |
| dc.contributor.author | Moretta, Lorenzo | * |
| dc.contributor.author | McVicar, Daniel W. | * |
| dc.contributor.author | Rossjohn, Jamie | * |
| dc.contributor.author | Brooks, Andrew G. | * |
| dc.contributor.author | Vivian, Julian P. | * |
| dc.date.accessioned | 2016-04-20T10:47:57Z | |
| dc.date.available | 2016-04-20T10:47:57Z | |
| dc.date.issued | 2016-04-04 | |
| dc.identifier.citation | Saunders, P. M., Pymm, P., Pietra, G., Hughes, V. A., Hitchen, C., O'Connor, G. M., Loiacono, F., Widjaja, J., Price, D. A., Falco, M., Mingari, M. C., Moretta, L., McVicar, D. W., Rossjohn, J., Brooks, A. G., & Vivian, J. P. (2016). Killer cell Immunoglobulin-like Receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. Journal of Experimental Medicine. http://dx.doi.org/10.1084/jem.20152023 | |
| dc.identifier.issn | 0022-1007 | en |
| dc.identifier.doi | 10.1084/jem.20152023 | |
| dc.identifier.uri | http://hdl.handle.net/10034/606045 | |
| dc.description | This is the authors accepted manuscript. | |
| dc.description.abstract | NK cells play a key role in immunity, but how HLA-I and KIR3DL1 polymorphism impacts on disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. This revealed different and distinct hierarchies of specificity for each KIR3DL1 allotype, with KIR3DL1*005 recognising the widest array of HLA-I ligands. These differences were further reflected in unctional studies utilising NK clones expressing these specific KIR3DL1 allotypes. Unexpectedly, the Ile/Thr80 dimorphism in the Bw4-motif did not categorically define strong/weak KIR3DL1 recognition. Although the KIR3DL1*001, *005 and *015 polymorphisms are remote from the KIR3DL1-HLA-I interface, the structures of these three KIR3DL1-HLA-I complexes showed that the broader HLA-I specificity of KIR3DL1*005 correlated with an altered KIR3DL1*005 interdomain positioning and increased mobility within its ligand-binding site. Collectively, we provide a generic framework for understanding the impact of KIR3DL1 polymorphism on the recognition of HLA-I allomorphs. | |
| dc.language.iso | en_US | en |
| dc.publisher | Rockefeller University Press | |
| dc.relation.url | http://jem.rupress.org/content/early/2016/03/29/jem.20152023.abstract | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
| dc.subject | Natural Killer Cells | en |
| dc.subject | KIR | en |
| dc.title | Killer cell Immunoglobulin-like Receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition | en_US |
| dc.type | Article | |
| dc.identifier.eissn | 1540-9538 | |
| dc.contributor.department | Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia; Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia; Department of Experimental Medicine, University of Genova, Genoa, 16132 Italy; IRCCS AOU San Martino-IST (National Institute for Cancer Research), Genoa, 16132 Italy; IRCCS Istituto Giannina Gaslini, Genoa, Italy; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; IRCCS Ospedale Pediatrico Bambino Gesù, Roma ITALY; Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD 21702, USA | |
| dc.identifier.journal | Journal of Experimental Medicine | en |
| dc.date.accepted | 2016-03-15 | |
| or.grant.openaccess | Yes | en |
| rioxxterms.funder | National Health and Medical Research Council (Australia); Worldwide cancer research organisation; The Intramural program of the National Cancer Institute; Wellcome Trust | en |
| rioxxterms.identifier.project | Externally Funded - not through Chester University | en |
| rioxxterms.version | AM | en |
| html.description.abstract | NK cells play a key role in immunity, but how HLA-I and KIR3DL1 polymorphism impacts on disease outcome remains unclear. KIR3DL1 (*001/*005/*015) tetramers were screened for reactivity against a panel of HLA-I molecules. This revealed different and distinct hierarchies of specificity for each KIR3DL1 allotype, with KIR3DL1*005 recognising the widest array of HLA-I ligands. These differences were further reflected in unctional studies utilising NK clones expressing these specific KIR3DL1 allotypes. Unexpectedly, the Ile/Thr80 dimorphism in the Bw4-motif did not categorically define strong/weak KIR3DL1 recognition. Although the KIR3DL1*001, *005 and *015 polymorphisms are remote from the KIR3DL1-HLA-I interface, the structures of these three KIR3DL1-HLA-I complexes showed that the broader HLA-I specificity of KIR3DL1*005 correlated with an altered KIR3DL1*005 interdomain positioning and increased mobility within its ligand-binding site. Collectively, we provide a generic framework for understanding the impact of KIR3DL1 polymorphism on the recognition of HLA-I allomorphs. |


